NCT03855111 - Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain | Biotech Hunter

Enrollment

196

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

October 21, 2024

Study Completion Date

October 21, 2024

Conditions

Neuropathic PainHIV NeuropathyHIV/AIDSPain

Interventions

OTHER

Standard Acupuncture / Moxibustion

Standard (Fixed) Active Acupuncture / Moxibustion protocol aimed at reducing lower limb neuropathic pain/discomfort.

OTHER

Individualized (Tailored) Active Acupuncture / Moxibustion

Individualized (tailored) protocol Acu/Moxa - Active. Acu/Moxa prescription based on TCM assessment. Protocol aimed at reducing lower limb neuropathic pain/discomfort.

Trial Locations (1)

10010

New York University, Division of Special Studies in Symptom Management, New York

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

lead

New York University

OTHER